# Evaluation of the Use of Machine Learning Techniques to Classify Neurodegenerative PARKinsonian Syndromes (Artificial Intelligence)

> **NCT05080296** · — · SUSPENDED · sponsor: **Central Hospital, Nancy, France** · enrollment: 1664 (estimated)

## Conditions studied

- DaTSCAN SPECT Scans

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05080296
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2021-12-20
- **Primary completion:** 2023-05-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 1664 (ESTIMATED)
- **Why stopped:** retrospective study
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05080296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05080296, "Evaluation of the Use of Machine Learning Techniques to Classify Neurodegenerative PARKinsonian Syndromes (Artificial Intelligence)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05080296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*